MWI Health

MWI Health in West Des Moines, Iowa provides Spravato (esketamine), an FDA-approved nasal spray for adults living with treatment-resistant depression. Spravato increases glutamate and acts on the NMDA receptor, allowing it to ease depressive symptoms far faster than conventional antidepressants, sometimes within 24 hours.

Spravato is approved both as a monotherapy and alongside an oral antidepressant, and it is the only drug besides lithium shown to reduce suicidal thoughts. Each dose is given under supervision in the clinic, followed by at least a two-hour monitoring period, so patients arrange transportation home.

The West Des Moines office offers Spravato within a wider range of care that includes psychotherapy and TMS therapy, with extended weekday evening hours to fit patients' schedules.